Van Damme4 1 Laboratory for Phytopathology and Plant Protection, Katholieke Universiteit Leuven, Belgium;2Dipartimento di Patologia sperimentale, Universita` di Bologna, Italy;3Rega Inst
Trang 1Analysis of the in planta antiviral activity of elderberry
ribosome-inactivating proteins
Frank Vandenbussche1, Stijn Desmyter1, Marialibera Ciani2, Paul Proost3, Willy J Peumans1
and Els J M Van Damme4
1
Laboratory for Phytopathology and Plant Protection, Katholieke Universiteit Leuven, Belgium;2Dipartimento di Patologia sperimentale, Universita` di Bologna, Italy;3Rega Institute, Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Belgium;4Department of Molecular Biotechnology, Gent University, Belgium
Although the type-2 ribosome-inactivating proteins (SNA-I,
SNA-V, SNLRP) from elderberry (Sambucus nigra L.) are
all devoid of rRNA N-glycosylase activity towards plant
ribosomes, some of them clearly show polynucleotide–
adenosine glycosylase activity towards tobacco mosaic virus
RNA This particular substrate specificity was exploited to
further unravel the mechanism underlying the in planta
antiviral activity of ribosome-inactivating proteins
Trans-genic tobacco (Nicotiana tabacum L cv Samsun NN) plants
expressing the elderberry ribosome-inactivating proteins
were generated and challenged with tobacco mosaic virus in
order to analyze their antiviral properties Although some
transgenic plants clearly showed antiviral activity, no clear
correlation was observed between in planta antiviral activity
of transgenic tobacco lines expressing the different
ribosome-inactivating proteins and the in vitro polynucleotide– adenosine glycosylase activity of the respective proteins to-wards tobacco mosaic virus genomic RNA However, our results suggest that the in planta antiviral activity of some ribosome-inactivating proteins may rely on a direct mech-anism on the virus In addition, it is evident that the working mechanism proposed for pokeweed antiviral protein cannot
be extrapolated to elderberry ribosome-inactivating proteins because the expression of SNA-V is not accompanied by induction of pathogenesis-related proteins
Keywords: elderberry; polynucleotide–adenosine glycosylase activity; ribosome-inactivating protein; Sambucus nigra; viral protection
Ribosome-inactivating proteins (RIPs; EC 3.2.2.22) are
a heterogeneous family of structurally and evolutionary
related plant proteins sharing a common functional domain
that catalytically removes a specific adenine residue from a
highly conserved, surface-exposed stem-loop structure
found in the large rRNA of prokaryotic and eukaryotic
ribosomes [1,2] At present, they are subdivided on the basis
of the structure of the genes and the corresponding proteins
into holo-RIPs and chimero-RIPs [3] Whereas holo-RIPs
consist exclusively of a single catalytically active protomer
of either one (classical type-1 RIPs) or two smaller
polypeptide chains (e.g maize RIP b-32), chimero-RIPs
are built up of chimeric protomers with an N-terminal
catalytically active domain arranged in tandem with a
structurally and functionally unrelated C-terminal domain (classical type-2 and type-3 RIPs)
Biochemical and molecular studies have shown that the elderberry tree expresses a complex mixture of type-2 RIPs and/or lectins in virtually all tissues In agreement with the chronological order of their discovery, these Sambucus nigra agglutinins (SNAs) are numbered SNA-I to SNA-V The first elderberry lectin was identified in bark tissue and described as a NeuAc(a-2,6)Gal/GalNAc-specific agglutinin (called SNA-I) [4,5] Although already discovered in 1984, SNA-I was recognized as a type-2 RIP only when the corresponding gene was cloned in 1996 [6] Besides SNA-I, elderberry bark contains a second NeuAc(a-2,6)Gal/Gal-NAc-specific agglutinin which shares 77% sequence simi-larity with SNA-I (but has a different oligomeric organization) and was called SNA-I¢ [7] The second lectin identified in elderberry bark was a GalNAc-specific agglu-tinin, called SNA-II with no obvious relation to SNA-I [5] However, molecular cloning of a GalNAc-specific elder-berry bark type-2 RIP (called SNA-V) later revealed that SNA-II consists of subunits that correspond to slightly truncated B chains of this genuine type-2 RIP Both SNA-V and SNA-II are derived from a single precursor, through differential processing [8] It should be mentioned here that SNA-V (or a very closely related paralog) was first described
by Girbes et al [9] as nigrin b After the identification of the bark lectins SNA-I and SNA-II, two other elderberry lectins called SNA-III and SNA-IV were isolated from seeds and
Correspondence to E J M Van Damme, Department of Molecular
Biotechnology, Ghent University, Coupure Links 653, 9000 Ghent,
Belgium Fax: + 32 9264 6219, Tel.: + 32 9264 6086,
E-mail: ElsJM.VanDamme@UGent.be
Abbreviations: PAG, polynucleotide–adenosine glycosylase; PAP,
pokeweed antiviral protein; PR, pathogenesis-related; RIP,
ribosome-inactivating protein; SNA, Sambucus nigra agglutinin; SNLRP,
Sambucus nigra lectin-related protein; TMV, tobacco mosaic virus.
Enzyme: Ribosome-inactivating protein, rRNA N-glycosylase
(EC 3.2.2.22).
(Received 16 January 2004, revised 24 February 2004,
accepted 27 February 2004)
Trang 2fruits, respectively Molecular cloning revealed that
SNA-IV, which is the most abundant fruit protein, is a dimeric
GalNAc-specific lectin encoded by a truncated type-2 RIP
gene (with a major deletion comprising almost the whole A
chain) [10] Besides the different SNAs, the bark of
elderberry contains an additional protein, SNLRP, which
is both structurally and evolutionary closely related to the
other elderberry type-2 RIPs but possesses a B chain which,
because of several amino-acid substitutions in the
sugar-binding sites, is devoid of carbohydrate-sugar-binding activity [11]
Initially, RIPs were thought to act exclusively on
ribosomes or rRNA through their rRNA N-glycosylase
activity However, using a highly sensitive
HPLC-fluores-cence-based method, Barbieri et al [12] showed that several
RIPs release more than one adenine residue from rRNA
Moreover, they found that saporin L1, a type-1 RIP from
the leaves of soapwort (Saponaria officinalis L.), is capable
of removing multiple adenine residues from various nucleic
acid substrates including herring sperm DNA, mammalian
DNA, genomic viral RNA, rRNA and poly(A) [13–15]
Additional testing of 61 RIPs revealed that all of them
extensively deadenylate herring sperm DNA and that
several are active towards viral genomic RNA [16–20]
On the basis of these findings it has been suggested that
polynucleotide–adenosine glycosylase (PAG) activity may
be responsible for the potent antiviral activity of RIPs
(against both animal and plant viruses) However, it is
still unclear whether the results obtained in these in vitro
studies can be extrapolated to the complex environment of
a cell [16]
Although the antiviral activity of RIPs against plant
viruses is well documented, the underlying mechanism(s) has
not yet been elucidated In principle, three possible
expla-nations can be put forward [3,21] First, RIPs may act
directly on the viral nucleic acids through their PAG activity
Secondly, RIPs may act directly on the host by selectively
killing the infected cells, thus preventing the virus from
replicating and spreading to neighboring cells Finally, RIPs
may act indirectly through activation of the plant’s defence
system As most RIPs with a documented strong in planta
antiviral activity [e.g pokeweed antiviral protein (PAP),
trichosanthin] are able to depurinate both viral nucleic acids
and plant ribosomes, it has been difficult to assess how the
PAG activity contributes to RIP-mediated protection To
further unravel the mode of action of RIPs, the in planta
antiviral activity of a set of type-2 RIPs (SNA-I, SNA-V,
SNLRP) from elderberry (S nigra L.) which are all devoid
of rRNA N-glycosylase activity towards plant ribosomes [9]
but strikingly differ from each other with respect to their
PAG activity towards tobacco mosaic virus (TMV) RNA,
was analyzed using a TMV/tobacco (Nicotiana tabacum L
cv Samsun NN) model system In addition to the genuine
type-2 RIP, the elderberry lectin SNA-IV, which is
consid-ered a type-2 RIP without an A chain, was included in the
study as a negative control A comparison of the protection
offered by the different ectopically expressed elderberry
RIPs did not reveal a clear correlation between in planta
antiviral activity and PAG activity towards TMV genomic
RNA However, it is evident that the working mechanism
suggested for PAP cannot be extrapolated to elderberry
RIPs because expression of the latter is not accompanied by
induction of pathogenesis-related (PR) proteins
Materials and methods
Plasmid constructions All manipulations were performed according to standard techniques [22] The pGK vector was constructed by replacing the b-glucuronidase gene from the plant transfor-mation vector pGPTV-KAN [23] with the expression cassette of the pFF19 vector [24] The coding sequences of the various RIPs/lectins were amplified by PCR to engineer appropriate restriction sites The restricted PCRproducts were inserted between the cauliflower mosaic virus 35S promoter and polyadenylation signal of the linearized and dephosphorylated pFF19 vector After confirmation of the sequence by dideoxy sequencing [25], inserts were subcloned into the expression cassette of the pGK plant transforma-tion vector The resulting plasmids, pGKsnaI, pGKsnaIV, pGKsnaV and pGKsnlrp, were transferred into Agrobacte-rium tumefaciensGV3101 by electroporation [26]
Transformation ofN tabacum Transformation of tobacco (N tabacum L cv Samsun NN) was performed using the leaf disc cocultivation method [27] Transgenic shoots were selected on Murashige-Skoog medium supplemented with 0.1 mgÆL)1 a-naphthalene acetic acid, 1 mgÆL)1 6-benzylaminopurine, 100 mgÆL)1 cefotaxime, 100 mgÆL)1carbenicillin and 100 mgÆL)1 kana-mycin (Duchefa Biochemie BV, Haarlem, the Netherlands) Transformed plants were kept in a culture room or a greenhouse at 22C, 50% relative humidity, and a 16 h photoperiod until use
Molecular analysis of transformants Total genomic DNA was isolated as described by Goode & Feinstein [28] The presence of the transgenes was investi-gated with PCRusing two internal primers derived from the N-terminal and C-terminal sequence of the various RIPs/ lectins Only the PCR-positive plants were further analysed
at the RNA and protein level
Total RNA was isolated as described by Eggermont et al [29], dissolved in RNase-free water, and quantified spectro-photometrically Approximately 30 lg total R NA was denatured with glyoxal/dimethyl sulfoxide and separated
on a 1.2% (w/v) agarose gel After electrophoresis, RNA was capillary blotted on to Hybond-N+membranes (Amersham Biosciences, Uppsala, Sweden) Membranes were first probed with random-primer-labeled cDNAs encoding the different RIPs/lectins or PR proteins (PR-1, PR-2, PR-3, proteinase inhibitor II) Subsequently the membranes were reprobed with a random-primer-labeled cDNA fragment complementary to the 3¢ end of the tobacco 25S rRNA
To estimate the expression levels of the different RIPs/ lectins, transgenic lines (T1 generation) were analysed for recombinant (r)RIP/lectin content by Western blot densi-tometry To minimize variation, 10 selfed plants of each line were grown under identical conditions (22C, 50% relative humidity, 16 h photoperiod) When plants reached the six-leaf stage, the third and fourth six-leaf were pooled, lyophilized, and ground using mortar and pestle Total protein from
50 mg lyophilized leaf material was extracted in 100 m
Trang 3Hepes (pH 7.6) The protein concentration was determined
using the Bio-Rad protein assay kit (Bio-Rad, Hercules, CA,
USA) using BSA as standard [30] For Western blot analysis,
2.5 lg (V), 7.5 lg (SNLRP) or 15 lg (I,
SNA-IV) total protein was separated by electrophoresis on a 15%
(w/v) SDS/polyacrylamide gel and transferred to an
Immo-bilon-P membrane (Millipore, Bedford, MA, USA) using a
Trans-blot SD semidry transfer cell (Bio-Rad)
Immuno-detection of the recombinant proteins was performed as
described by Desmyter et al [31] using affinity-purified
polyclonal rabbit antibodies raised against native SNA-I,
SNA-II or SNLRP as the primary antibody
Purification of recombinant proteins
rRIPs were isolated using a combination of classical protein
purification techniques and affinity chromatography (except
for SNLRP, which possesses no sugar-binding activity) For
the purification of recombinant SNA-I, leaves of SNA-I
transformants were homogenized in a solution of 1 gÆL)1
ascorbic acid using a Waring blender After centrifugation
at 3000 g for 10 min, 1 gÆL)1 CaCl2 was added to the
supernatant, and the pH adjusted to 9.0 with 0.5MNaOH
The extract was cleared by centrifugation at 8000 g for
10 min and filtered through Whatman 3MM filter paper
The filtrate was subsequently adjusted to pH 2.8 with 0.5M
HCl and loaded on to a column (2.6 cm· 10 cm; 50 mL
bed volume) of S Fast Flow (Amersham Biosciences,
Uppsala, Sweden) equilibrated with 20 mM acetic acid
After loading, the column was washed with 20 mMacetic
acid until the A280fell below 0.01, and the bound proteins
were eluted with 300 mL 0.1MTris/HCl (pH 8.7)
contain-ing 0.5MNaCl This partially purified protein fraction was
adjusted to pH 7.0 with 0.5M NaOH and loaded on a
column (1.6 cm· 5 cm; 10 mL bed volume) of fetuin–
Sepharose 4B equilibrated with 0.2M NaCl After the
column had been washed with 0.2MNaCl, the bound lectin
was desorbed with 20 mM 1,3-diaminopropane (pH 9.0)
and stored at)20 C until use
For the purification of recombinant IV and
SNA-V, leaves of SNA-IV and SNA-V transformants were
homogenized in 20 mMcitric acid (pH 3.0) using a Waring
blender The crude extract was cleared by centrifugation at
3000 g for 10 min and filtered through Whatman 3MM
filter paper (NH4)2SO4was added to a final concentration
of 1.5Mand the pH adjusted to 7.0 with 0.5MNaOH The
extract was then applied to a column (2.6 cm· 10 cm;
50 mL bed volume) of galactose–Sepharose 4B equilibrated
with 1.5M(NH4)2SO4 After the column had been washed
with 1.5M(NH4)2SO4until the A280fell below 0.01, bound
proteins were desorbed with 0.2M galactose in 1.5M
(NH4)2SO4 The affinity-purified proteins were loaded on
a column (1.6· 10 cm; 20 mL bed volume) of
phenyl-Sepharose (Amersham Biosciences) equilibrated with 1.5M
(NH4)2SO4 After the column had been washed with 1.5M
(NH4)2SO4, the protein was desorbed with 20 mM
1,3-diaminopropane (pH 9.0) Fractions (2.5 mL each) were
collected and analysed by SDS/PAGE Peak fractions
containing the RIPs/lectins were pooled and stored at
)20 C until use
For the purification of rSNLRP, leaves from SNLRP
transformants were homogenized in 50 m acetic acid
using a Waring blender After adjustment of the pH to 3.0 with 0.5MHCl, the homogenate was centrifuged at 3000 g for 10 min and filtered through Whatman 3MM filter paper The cleared filtrate was then loaded on a column (2.6 cm· 10 cm; 50 mL bed volume) of S Fast Flow (Amersham Biosciences) equilibrated with 20 mM acetic acid After the column had been washed with 100 mL
25 mMsodium formate (pH 3.8), the bound proteins were desorbed with a linear gradient (500 mL) of increasing NaCl concentration (from 0 to 0.5M) Fractions (5 mL each) were collected and analysed by SDS/PAGE Peak fractions containing SNLRP were pooled, concentrated by freeze-drying, and loaded on a column (2.6 cm· 70 cm;
350 mL bed volume) of Sephacryl 100 equilibrated with
10 mM Tris/HCl (pH 7.5) for gel filtration Finally, frac-tions (2.5 mL each) were collected and analysed with SDS/ PAGE Peak fractions containing SNLRP were pooled and stored at)20 C until use
Protein sequencing Purified recombinant proteins were analysed by SDS/ PAGE and transferred to ProBlottTMmembranes (Applied Biosystems, Foster City, CA, USA) using a Trans-blot SD semidry transfer cell Proteins were excised from the blots and sequenced on a Procise 491 cLC protein sequencer (Applied Biosystems)
Enzyme assay The N-glycosylase activity of crude tobacco extracts or recombinant proteins towards rRNA was determined as described previously using rabbit reticulocyte ribosomes as substrate [32]
The PAG activity of the native RIPs was determined by measuring the adenine released from the substrate as described by Brigotti et al [33] Reactions were performed
in Eppendorf tubes containing 1 pmol RIP and 5 lg substrate (TMV genomic RNA) in 50 lL PAG buffer (50 mM sodium acetate, 100 mM KCl, pH 4.0) After
40 min incubation at 30C, the adenine released was quantified by LC/MS on a Waters Alliance/ZQ apparatus (Waters Corporation, Milford, MA, USA)
TMV bioassays Based on the molecular analysis, five transgenic lines per construct (SNA-I, SNA-IV, SNA-V, SNLRP) were ran-domly chosen to study their level of protection against TMV infection Wild-type and transgenic (T1-generation) tobacco plants were grown to the six-leaf stage in a culture room at
22C under a 16 h photoperiod Plants were mechanically inoculated by rubbing the upper two fully expanded leaves with a virus suspension [1 lgÆmL)1TMV in 0.1MKH2PO4, 2% (w/v) polyvinylpyrrolidone, pH 7.2] in the presence of carborundum After infection, plants were maintained in
a greenhouse at 22C, 50% relative humidity, and a 16 h photoperiod Four days after infection the total number of lesions on both leaves was counted To minimize variation,
a complete randomised block design was used Experiments were repeated three times Before analysis, the dataset was transformed to the logarithmic scale The transformed data
Trang 4were analysed using analysis of variance, and means were
compared using a Tukey’s HSD multiple range test
(a¼ 0.05)
Induction of PR proteins
The possible constitutive expression of PRproteins in
transgenic plants expressing the different RIPs/lectins was
checked by Northern blot analysis Total RNA was
isolated, separated by agarose gel electrophoresis, and
blotted Blots were hybridized with specific probes for PR-1,
PR-2, PR-3 and proteinase inhibitor II [34]
Results and discussion
PAG activity towards TMV genomic RNA
To corroborate the possible relation between the PAG and
antiviral activity of RIPs, native elderberry RIPs were tested
for their depurinating activity towards TMV genomic RNA
(Table 1) Of the RIPs tested, both SNA-V and SNLRP
exhibited weak PAG activity towards TMV genomic RNA,
whereas SNA-I showed no activity under the same
experi-mental conditions This complete lack of PAG activity for
SNA-I is most probably due to its intrinsically lower
enzymatic activity As previously shown, SNA-I exhibits a
markedly lower PAG activity on different nucleic acid
substrates than other type-2 RIPs (possibly as a result of its
complex tetrameric structure) [35,36] As none of the
elderberry RIPs display enzymatic activity towards plant
ribosomes in rRNA N-glycosylase activity assays [9], they
are ideal candidates for assessing whether the PAG activity
is involved in RIP-mediated protection
Expression of SNA-I, SNA-IV, SNA-V and SNLRP
in transgenic tobacco
Tobacco leaf discs were transformed with A tumefaciens
GV3101 harboring the various pGKrip/lectin vectors The
RIP/lectin-expressing plants are hereafter referred to as
RIP/n where RIP denotes the RIP/lectin expressed and n
the number No visible phenotypic aberrations were
observed in any of the RIP/lectin-expressing transformants,
indicating that these elderberry type-2 RIPs exert no
cytotoxic effects in planta
All plants obtained after transformation were analysed by
PCRto confirm the presence of the RIP/lectin coding
sequence in the tobacco genome Only those plants that
were positive in the PCRanalysis were withheld for further
analysis Expression of the RIP/lectin transgenes was
examined by analysing all transgenic lines (T0generation)
at the RNA and protein level Transcription products of the predicted size were detected in most transformants but never in wild-type plants (data not shown) Western blot analysis of crude leaf extracts confirmed that most of these transformants contained immunoreactive bands As only a limited number of transformants could be analysed in the viral bioassay, five lines per construct were randomly chosen for a more detailed analysis To estimate the expression levels of the RIPs/lectins, transgenic lines (T1 generation) were analysed for rRIP/lectin content by Western blot densitometry (Fig 1, Table 2) The highest expression levels were observed for the SNA-V lines, in which the RIP accounted for 0.8–5.0% of the total soluble leaf protein All other lines exhibited markedly lower expression levels of recombinant RIPs/lectins, varying between 0.03% and 1.7% of the total soluble protein To verify whether the rRIPs are enzymatically active, crude extracts from four different RIP/lectin-expressing transformants (SNA-I/4, SNA-IV/3, SNA-V/4 and SNLRP/2) were analysed for the presence of rRNA N-glycosylase activity The SNA-IV transformant was included as a negative control As shown
in Fig 2A, the characteristic Endo fragment was only detected in the SNA-V and SNLRP transformants (lanes 6 and 8), but not in the SNA-I and SNA-IV transformants (lanes 2 and 4) The lack of enzymatic activity in the SNA-I
Table 1 RIP-catalysed release of adenine (pmol per pmol RIP per
40 min) from TMV genomic RNA.
a
Statistically significantly at P<0.02.
Fig 1 Western blot analysis of total soluble protein from wild-type and transgenic tobacco plants Approximately 15 lg (SNA-I, SNA-IV), 7.5 lg (SNLRP) or 2.5 lg (SNA-V) total soluble protein was separ-ated in a 15% (w/v) SDS/polyacrylamide gel and transferred to a nylon membrane Membranes were probed with polyclonal rabbit antibodies raised against the different RIPs/lectins Sample loading was as fol-lows: lane –, wild-type; lane +, pure native R IP/lectin; lanes 1–5, R IP/ 1–5; lane 6–12, serial dilution (400–6.25 ng) of native pure RIP/lectin.
Table 2 Expression levels (% of total soluble protein) of recombinant elderberry RIPs/lectins in transgenic tobacco plants in the different line numbers.
SNA-IV 0.03 1.0 1.7 0.4 0.4
Trang 5transformants was presumably due to the lower expression
levels in these transformants and the intrinsically lower
enzymatic activity of SNA-I
Purification and characterization of recombinant proteins
Recombinant SNA-I, SNA-IV, SNA-V and SNLRP were
purified from leaves of transgenic tobacco plants, and their
purity confirmed by SDS/PAGE and Western blot analysis
Staining of the gels with Coomassie Brilliant Blue yielded
virtually identical migration patterns for the native and
recombinant proteins (Fig 3), indicating that the rRIPs/
lectins were electrophoretically pure Moreover, the
pres-ence of high-molecular-mass bands in the lanes with
unreduced rSNA-I suggests that it adopts the same
[A-s-s-B-s-s-B-s-s-A]2structure as native SNA-I However, the presence of a faster migrating band in unreduced
rSNA-I suggests that the intermolecular disulfide bridge formation between the two [A-s-s-B] pairs is less efficient in tobacco than in elderberry Upon reduction, the high-molecular-mass bands of both rSNA-I and SNA-I disappeared giving rise to two polypeptides of nearly identical mass All other RIPs (SNA-V, SNLRP) yielded a banding pattern typical
of type-2 RIPs (i.e characterized by the presence of two distinct polypeptides of 30 and 35 kDa, respectively), indicating that they are composed of [A-s-s-B] protomers
As antibodies to SNA-II were used to detect SNA-V, no antibodies directed against the A chain were present and accordingly only the B chain of SNA-V could be visualized
in the Western blot analysis In contrast with elderberry bark where 95% of the SNA-V precursor is converted into SNA-II and only 5% in SNA-V, the SNA-V-expressing tobacco plants contained little or no rSNA-II, indicating that in tobacco the precursor of rSNA-V is exclusively converted into the genuine type-2 RIP SNA-V The molecular structure of the recombinant RIPs/lectins was further analysed by gel filtration on a Superose 12 column
As expected, the native and recombinant proteins were eluted at the same position (data not shown) Furthermore N-terminal sequencing of the recombinant proteins con-firmed that tobacco cells successfully recognize and cleave the signal peptide as well as the internal linker peptide at exactly the same positions as in the parent plant (data not shown) Analysis of the rRNA N-glycosylase activity using rabbit ribosomes as a substrate demonstrated that both purified rSNA-V and rSNLRP exhibited strong enzymatic activity (Fig 2B, lanes 6 and 8) whereas no activity could be detected for the purified rSNA-IV (lane 4), which served as a negative control However, in contrast with the results of the enzymatic assays with crude extracts, a clear signal was also observed for purified rSNA-I (lanes 2) These results clearly show that all rRIPs are enzymatically active Similar results were recently also reported for SNA-If and SNA-I¢ [37,38]
Fig 2 rRNA N-glycosylase activity of crude extracts from five different
RIP/lectin-expressingtransformants (A) or purified recombinant RIPs/
lectins (B) towards rabbit reticulocyte ribosomes The arrow indicates
the position of the Endo fragment released from the rRNA (–) and
(+) indicate no treatment and aniline treatment, respectively Sample
loading was as follows: lanes 1 and 2, SNA-I/4; lanes 3 and 4, SNA-IV/
3; lanes 5 and 6, SNA-V/4; lanes 7 and 8, SNLRP/2.
Fig 3 SDS/PAGE (left hand panel) and Western blot (right hand panel) analysis of purified native and recombinant RIPs/lectins under nonreducing(A) and reducing(B) conditions Sample loading was as follows: lane 1, SNA-I; lane 2, I; lane 3, SNA-IV; lane 4, rSNA-IV; lane 5, SNA-V; lane 6, rSNA-V; lane 7, SNLR P; lane 8, rSNLR P Molecular mass markers were phosphorylase b (97 kDa), albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa), trypsin inhibitor (20 kDa) and lysozyme (14 kDa).
Trang 6The results presented here and elsewhere thus indicate that
tobacco is not only capable of correctly processing and
assembling monomeric (SNLRP) but also dimeric (SNA-I¢,
SNA-V) and even tetrameric (SNA-I, SNA-If) type-2 RIPs
TMV bioassays
To assess whether and, if so, to what extent the elderberry
RIPs provide in planta protection against viruses
(non)trans-genic control plants and RIP-expressing tobacco plants (T1
generation) were challenged with TMV For each RIP, five
transgenic lines were randomly chosen to be analysed in the
bioassays As SNA-IV lacks the catalytically active A chain,
it is expected to confer no protection against viruses and
hence serves as a negative control To minimize variation, a
complete randomised block design was used, with each
block consisting of a nontransgenic control plant
(wild-type), a transgenic control plant (empty-vector) and five
RIP-expressing transgenic plants (RIP/1–5) Three
inde-pendent experiments were set up for each RIP
Experimen-tal data were combined to calculate the mean number of
lesions, which were compared using a Tukey’s HSD
multiple range test (a¼ 0.05) Significant differences
between control and RIP-expressing plants were only
observed for SNA-V (SNA-V/1, SNA-V/3, SNA-V/4)
(Table 3) Interestingly, a direct correlation was observed
between the expression level of rSNA-V and the level of
protection against TMV in the different SNA-V lines Only
the three lines with the highest protection levels showed a
significant reduction in lesion numbers compared with
control plants Although these results show that the type-2
RIP SNA-V is capable of conferring local protection against
TMV infection, the level of protection is markedly lower
than that of type-1 RIPs On average, the three highest
expressing SNA-V lines showed a reduction in lesion
numbers of 39% Using the same bioassay, Desmyter et al
[31] showed that IRIP, a type-1 RIP from Iris hollandica L.,
provides high levels of protection for transgenic tobacco
plants, with an average reduction in lesion numbers of 75%
Moreover, all five IRIP-expressing lines exhibited similar
protection levels The observation that SNA-V provides
protection only at very high expression levels (> 3.7% of the
total soluble protein) suggests that the antiviral mechanism
of SNA-V differs from that of IRIP Like most type-1 RIPs,
IRIP exhibits rRNA N-glycosylase activity towards both
animal and plant ribosomes [39], and accordingly is capable
of depurinating in planta part of the ribosomes in
IRIP-expressing tobacco on TMV infection (as could be
demon-strated by an in planta depurination assay) [40] Thus, the
strong in planta antiviral activity of IRIP is presumably due
to its direct depurinating activity towards both viral nucleic
acids and plant ribosomes and hence relies on a direct effect
on both the invading viruses and the infected cells As
SNA-V does not act on plant ribosomes, the elderberry RIP can
only act on the virus itself and not on the infected cells, which
may explain why it provides less protection against viral
infection than IRIP or other type-1 RIP
Although both SNA-V and SNLRP exhibited similar
depurination rates on TMV genomic RNA (Table 1), only
the highest SNA-V-expressing lines showed a significant
reduction in TMV lesion numbers However, as mentioned
above, the SNA-V lines showed markedly higher expression
levels than any of the other RIP-expressing tobacco lines These results suggest that in planta depurination of viral nucleic acids requires high cellular RIP concentrations Similar results were recently reported for the cap-specific depurination by the type-1 RIP PAP from pokeweed [41] Using a filter-binding assay, the authors demonstrated that PAP has a nearly fourfold lower affinity for capped RNAs than for rRNA As a consequence, PAP is only expected to significantly interact with capped RNAs at high cellular concentrations and/or high capped RNA levels It is likely therefore that the ectopically expressed SNLRP exerts no protection in planta because its expression level remains below the threshold concentration required for activity
Analysis of PR protein expression in transgenic tobacco plants
As according to previous reports the ectopic expression of PAP and various PAP mutants resulted in constitutive expression of some PRproteins [42,43], it seemed worth
Table 3 Susceptibility of wild-type and transgenic tobacco plants to TMV infection The mean number of lesions was calculated for each RIP separately and compared using a Tukey’s HSD multiple range test (a ¼ 0.05) Inhibition percentages were calculated by the following formula: 100 · (number of lesions wild-type – number of lesions transformant)/number of lesions wild-type When the number of lesions of the transformant was as high or higher than the wild-type value, the inhibition percentage was set to zero.
Tobacco line
Number
of plants
Number of lesions
Inhibition (%) Wild-type 26 151 ± 67 A 0 Empty vector 26 140 ± 47 A 7 SNA-I/1 26 113 ± 56 A 25 SNA-I/2 25 133 ± 68 A 12
SNA-I/4 26 122 ± 57 A 19
Wild-type 24 149 ± 60 A 0 Empty vector 24 152 ± 27 A 0 SNA-IV/1 24 158 ± 56 A 0 SNA-IV/2 24 145 ± 69 A 3 SNA-IV/3 24 131 ± 63 A 12 SNA-IV/4 24 112 ± 37 A 25 SNA-IV/5 24 123 ± 36 A 17 Wild-type 28 146 ± 77 A 0 Empty vector 28 141 ± 62 A 3
Wild-type 24 208 ± 128 A 0 Empty vector 24 167 ± 99 A 20
SNLRP/2 24 197 ± 115 A 5 SNLRP/3 24 179 ± 93 A 14
Trang 7while to check whether the same phenomenon occurs in
tobacco plants that synthesize one of the elderberry type-2
RIPs/lectins Therefore, the presence of mRNAs encoding
PR-1, PR-2, PR-3 and proteinase inhibitor II was verified
by Northern blot analysis In none of the transgenic plants
could any of these mRNAs be detected (data not shown),
indicating that constitutive expression of neither the type-2
RIPs SNA-V, SNA-I and SNLRP nor the lectin SNA-IV
was accompanied by an increase in acidic or basic PR
proteins Similar results were recently also reported for
transgenic tobacco plants expressing IRIP or SNA-I¢
[31,37,38] In spite of enhanced protection levels against
TMV infection, none of these plants constitutively
accu-mulated PRproteins The results presented here and
elsewhere thus clearly indicate that the proposed mode of
action of PAP (i.e through activation of the plant’s defence
system) cannot be generalized to other RIPs
Acknowledgements
This work was supported in part by grants from the Katholieke
Universiteit Leuven and DG6 Ministerie voor Middenstand en
Landbouw-Bestuur voor Onderzoek en Ontwikkeling P P is a
Postdoctoral Fellow of the Fund for Scientific Research-Flanders The
work performed in Bologna was partially supported by Progetto
Strategico Oncologia n.74 (DD 19Ric, 09/01/02) from Ministero
Istruzione Universita` e Ricerca, Italy The TMV strain was a gift from
Professor M Ho¨fte (Laboratory of Phytopathology, Ghent University,
Belgium).
References
1 Endo, Y., Mitsui, K., Motizuki, M & Tsurugi, K (1987) The
mechanism of action of ricin and related toxic lectins on
eu-karyotic ribosomes The site and the characteristics of the
mod-ification in 28 S ribosomal RNA caused by the toxins J Biol.
Chem 262, 5908–5912.
2 Endo, Y & Tsurugi, K (1987) RNA N-glycosidase activity of
ricin A-chain Mechanism of action of the toxic lectin ricin on
eukaryotic ribosomes J Biol Chem 262, 8128–8130.
3 Van Damme, E.J.M., Hao, Q., Chen, Y., Barre, A.,
Vandenbus-sche, F., Desmyter, S., Rouge´, P & Peumans, W.J (2001)
Ribo-some-inactivating proteins: a family of plant proteins that do more
than inactivate ribosomes Crit Rev Plant Sci 20, 395–465.
4 Broekaert, W.F., Nsimba-Lubaki, M., Peeters, B & Peumans,
W.J (1984) A lectin from elder (Sambucus nigra L.) bark
Bio-chem J 221, 163–169.
5 Kaku, H., Peumans, W.J & Goldstein, I.J (1990) Isolation
and characterization of a second lectin (SNA-II) present in
el-derberry (Sambucus nigra L.) bark Arch Biochem Biophys 277,
255–262.
6 Van Damme, E.J.M., Barre, A., Rouge´, P., Van Leuven, F &
Peumans, W.J (1996) The NeuAc (alpha-2,6)
-Gal/GalNAc-binding lectin from elderberry (Sambucus nigra) bark, a type-2
ribosome-inactivating protein with an unusual specificity and
structure Eur J Biochem 235, 128–137.
7 Van Damme, E.J.M., Roy, S., Barre, A., Citores, L.,
Mostafa-pous, K., Rouge´, P., Van Leuven, F., Girbes, T., Goldstein, I.J &
Peumans, W.J (1997) Elderberry (Sambucus nigra) bark contains
two structurally different Neu5Ac(alpha2,6)Gal/GalNAc-binding
type 2 ribosome-inactivating proteins Eur J Biochem 245,
648–655.
8 Van Damme, E.J.M., Barre, A., Rouge´, P., Van Leuven, F &
Peumans, W.J (1996) Characterization and molecular cloning of
Sambucus nigra agglutinin V (nigrin b), a GalNAc-specific type-2 ribosome-inactivating protein from the bark of elderberry (Sam-bucus nigra) Eur J Biochem 237, 505–513.
9 Girbes, T., Citores, L., Ferreras, J.M., Rojo, M.A., Iglesias, R., Munoz, R., Arias, F.J., Calonge, M., Garcia, J.R & Mendez, E (1993) Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark of Sambucus nigra L Plant Mol Biol 22, 1181–1186.
10 Van Damme, E.J.M., Roy, S., Barre, A., Rouge´, P., Van Leuven,
F & Peumans, W.J (1997) The major elderberry (Sambucus nigra) fruit protein is a lectin derived from a truncated type 2 ribosome-inactivating protein Plant J 12, 1251–1260.
11 Van Damme, E.J.M., Barre, A., Rouge´, P., Van Leuven, F & Peumans, W.J (1997) Isolation and molecular cloning of a novel type 2 ribosome-inactivating protein with an inactive B chain from elderberry (Sambucus nigra) bark J Biol Chem 272, 8353–8360.
12 Barbieri, L., Ferreras, J.M., Barraco, A., Ricci, P & Stirpe, F (1992) Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites Biochem J 286, 1–4.
13 Barbieri, L., Gorini, P., Valbonesi, P., Castiglioni, P & Stirpe, F (1994) Unexpected activity of saporins Nature (London) 372, 624.
14 Barbieri, L., Valbonesi, P., Gorini, P., Pession, A & Stirpe, F (1996) Polynucleotide:adenosine glycosidase activity of sapor-in-L1: effect on DNA, RNA and poly (A) Biochem J 319, 507– 513.
15 Barbieri, L., Valbonesi, P., Govoni, M., Pession, A & Stirpe, F (2000) Polynucleotide:adenosine glycosidase activity of saporin-L1: effect on various forms of mammalian DNA Biochim Biophys Acta 1480, 258–266.
16 Barbieri, L., Valbonesi, P., Bonora, E., Gorini, P., Bolognesi, A & Stirpe, F (1997) Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly (A) Nucleic Acids Res 25, 518–522.
17 Bolognesi, A., Polito, L., Olivieri, F., Valbonesi, P., Barbieri, L., Battelli, M.G., Carusi, M.V., Benvenuto, E., Del Vecchio, B.F., Di Maro, A., Parente, A., Di Loreto, M & Stirpe, F (1997) New ribosome-inactivating proteins with polynucleotide:adenosine glycosidase and antiviral activities from Basella rubra L & Bou-gainvillea spectabilis Willd Planta 203, 422–429.
18 Di Maro, A., Valbonesi, P., Bolognesi, A., Stirpe, F., De Luca, P., Siniscalco, G.G., Gaudio, L., Delli, B.P., Ferranti, P., Malorni, A.
& Parente, A (1999) Isolation and characterization of four type-1 ribosome-inactivating proteins, with polynucleotide:adenosine glycosidase activity, from leaves of Phytolacca dioica L Planta
208, 125–131.
19 Rajamohan, F., Venkatachalam, T.K., Irvin, J.D & Uckun, F.M (1999) Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1 Biochem Biophys Res Commun 260, 453–458.
20 Bolognesi, A., Polito, L., Lubelli, C., Barbieri, L., Parente, A & Stirpe, F (2002) Ribosome-inactivating and adenine polynucleo-tide glycosylase activities in Mirabilis jalapa L tissues J Biol Chem 277, 13709–13716.
21 Peumans, W.J., Hao, Q & Van Damme, E.J.M (2001) Ribo-some-inactivating proteins from plants: more than RNA N-gly-cosidases? FASEB J 15, 1493–1506.
22 Sambrook, J., Fritsch, E.F & Maniatis, T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
23 Becker, D., Kemper, E., Schell, J & Masterson, R (1992) New plant binary vectors with selectable markers located proximal to the left T-DNA border Plant Mol Biol 20, 1195–1197.
24 Timmermans, M., Maliga, P., Vieira, J & Messing, J (1990) The pFF plasmids: cassettes utilising CaMV sequences for expression
of foreign genes in plants J Biotechnol 14, 333–334.
Trang 825 Sanger, F., Nicklen, S & Coulson, A.R (1977) DNA sequencing
with chain-terminating inhibitors Proc Natl Acad Sci USA 74,
5463–5467.
26 Shen, W.J & Forde, B.G (1989) Efficient transformation of
Agrobacterium spp by high voltage electroporation Nucleic Acids
Res 17, 8385.
27 Horsch, R.B., Fry, J.E., Hoffmann, N.L., Eichholtz, D., Rogers,
S.G & Fraley, R.T (1985) A simple and general method for
transferring genes into plants Science 227, 1229–1231.
28 Goode, B.L & Feinstein, S.C (1992) Speedprep purification of
template for double-stranded DNA sequencing Biotechniques 12,
374–375.
29 Eggermont, K., Goderis, I.J & Broekaert, W.F (1996)
High-throughput RNA extraction from plant samples based on
homogenisation by reciprocal shaking in the presence of a mixture
of sand and glass beads Plant Mol Biol Rep 14, 273–279.
30 Bradford, M.M (1976) A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding Anal Biochem 72, 248–254.
31 Desmyter, S., Vandenbussche, F., Hao, Q., Proost, P., Peumans,
W.J & Van Damme, E.J.M (2003) Type-1 ribosome-inactivating
protein from iris bulbs: a useful agronomic tool to engineer virus
resistance? Plant Mol Biol 51, 567–576.
32 Van Damme, E.J.M., Hao, Q., Charels, D., Barre, A., Rouge´, P.,
Van Leuven, F & Peumans, W.J (2000) Characterization and
molecular cloning of two different type 2 ribosome-inactivating
proteins from the monocotyledonous plant Polygonatum
multi-florum Eur J Biochem 267, 2746–2759.
33 Brigotti, M., Alfieri, R., Sestili, P., Bonelli, M., Petronini, P.G.,
Guidarelli, A., Barbieri, L., Stirpe, F & Sperti, S (2002) Damage
to nuclear DNA induced by Shiga toxin 1 and ricin in human
endothelial cells FASEB J 16, 365–372.
34 Ward, E.R., Uknes, S.J., Williams, S.C., Dincher, S.S.,
Wieder-hold, D.L., Alexander, D.C., Ahl-Goy, P., Me´traux, J.-P & Ryals,
J.A (1991) Coordinate gene activity in response to agents that
induce systemic acquired resistance Plant Cell 3, 1085–1094.
35 Battelli, M.G., Barbieri, L., Bolognesi, A., Buonamici, L., Valbonesi, P., Polito, L., Van Damme, E.J.M., Peumans, W.J & Stirpe, F (1997) Ribosome-inactivating lectins with poly-nucleotide:adenosine glycosidase activity FEBS Lett 408, 355–359.
36 Barbieri, L., Ciani, M., Girbes, T., Liu, W.-Y., Van Damme, E.J.M., Peumans, W.J & Stirpe, F (2004) Enzymatic activity of toxic and non-toxic type 2 ribosome-inactivating proteins FEBS Lett in press.
37 Chen, Y., Vandenbussche, F., Rouge´, P., Proost, P., Peumans, W.J & Van Damme, E.J.M (2002) A complex fruit-specific type-2 ribosome-inactivating protein from elderberry (Sambucus nigra) is correctly processed and assembled in transgenic tobacco plants Eur J Biochem 269, 2897–2906.
38 Chen, Y., Peumans, W.J & Van Damme, E.J.M (2002) The Sambucus nigra type-2 ribosome-inactivating protein SNA-I¢ exhibits in planta antiviral activity in transgenic tobacco FEBS Lett 516, 27–30.
39 Hao, Q., Van Damme, E.J.M., Hause, B., Barre, A., Chen, Y., Rouge´, P & Peumans, W.J (2001) Iris bulbs express type 1 and type 2 ribosome-inactivating proteins with unusual properties Plant Physiol 125, 866–876.
40 Desmyter, S (2002) Study of the antiviral activity of IRIP, a
type-1 ribosome-inactivating protein from Iris hollandica PhD Thesis, Katholieke Universiteit Leuven, Belgium.
41 Hudak, K.A., Bauman, J.D & Tumer, N.E (2002) Pokeweed antiviral protein binds to the cap structure of eukaryotic mRNA and depurinates the mRNA downstream of the cap RNA 8, 1148–1159.
42 Zoubenko, O., Uckun, F., Hur, Y., Chet, I & Tumer, N (1997) Plant resistance to fungal infection induced by nontoxic pokeweed antiviral protein mutants Nat Biotechnol 15, 992–996.
43 Zoubenko, O., Hudak, K & Tumer, N.E (2000) A non-toxic pokeweed antiviral protein mutant inhibits pathogen infection via
a novel salicylic acid-independent pathway Plant Mol Biol 44, 219–229.